Chinese medicine into the collection? The NATIONAL Health Service responded

Recently, a proposal concerning the collection of Chinese medicine has aroused concern in the industry.
November 30, the State Health Insurance Administration responded to a question on the collection of Chinese medicine in a "letter on the reply to proposal No. 3181 (Medical Sports No. 459) of the third session of the 13th National Committee of the CPPCC". The
reply letter states that it will continue to "guide local procurement of centralized quantities of medicines, improve procurement methods according to clinical drug demand, reasonably determine the scope of collection and collection, ensure the quality and supply of medicines and meet the needs of the masses;
" At present, Qinghai Province, Zhejiang Jinhua, Henan Puyang and other places, in view of some of the large demand, high amount of Chinese medicine species, and actively carry out mining exploration, achieved remarkable price reduction results, reform results to benefit more people.
" all over the test water into the drug collection is currently carried out in 3 batches of drugs collection, chemical drugs are still mainstream, but in fact, on the issue of the collection of Chinese medicine, from the State Health Insurance Bureau to industry authorities, there is news, since July 17 this year held a centralized procurement symposium, research and improve the relevant procurement policies, the State Health Insurance Bureau has repeatedly stressed that the Chinese medicine, biological medicine will carry out volume procurement.
currently Qinghai, Henan, Zhejiang Jinhua and other local levels have begun to test the amount of water into the drug belt procurement.
according to public information, Qinghai was the first batch of biological products, Chinese medicine and Chinese medicine injections into the collection of the region.
According to the results announced in July, Qinghai will be the province's public medical institutions at all levels to report 70% of the total procurement volume for the agreed procurement volume, a total of 59 drugs involved in Qinghai Province belt procurement, of which 37 are injections, including Chinese medicine injections, biological agents There are eye drops and inhalers, among which the amount of chinese medicine purchased involves magpie injection, injection with blood plug (freeze-dried), injection with dansan polyphenols, sputum hydrochloride injections and other large varieties of Chinese medicine injections.
For Henan Province, as reported by Saibai Blue, according to the results of the selection of the first centralized drug procurement varieties in Henan Province, four headaches, including tyrannine, sodium 7 leaf saponin, glucosin and sichuan pyridorea injections, as well as Chinese medicine injections in the field of cerebrovascular diseases are also listed.
In June Jinhua City announced the second batch of volume procurement of the proposed enterprises and varieties, a total of 93 products, of which 39 are Chinese medicine, including ginseng injection, compound dansin tablets, six-flavored yellow pills, clear open spirit particles and other Chinese medicine.
according to Jinhua's rules, these drugs on the basis of high price limits, the price reduction can not be less than 10%, some products will be reduced by more than 20%.
in addition to the above-mentioned areas, in July this year, Liaoning Province also issued a message that 13 varieties will be carried out with volume procurement, involving gas and blood kang oral solution, Yunnan white medicine hemorrhoid cream, the first vera pass capsule, children's wood to clear particles, joint analgesic barb paste, anti-ointment, pro-female cream and other 7 Chinese medicine.
the difficulties and characteristics of chinese medicine collection, according to Saibai Blue reported, industry insiders said that the chinese medicine negotiations procurement and centralized procurement, the biggest difficulty lies in the "standards."
Most of the Chinese medicine products, can only be defined by the treatment location or treatment field, it is difficult to measure by consistent evaluation criteria, some of the scope of drug adaptation is unclear, clinical application is wide, how to achieve a reasonable delineation of adaptive disorders is difficult.
Second, most traditional Chinese medicine for the exclusive varieties or exclusive dosage forms, even if not exclusive varieties, it is affected by the origin of medicinal herbs, processing processes, dosage forms and other factors, it is not possible to form a certain measurable standard.
Therefore, the future active ingredients are relatively clear, adaptive clear Ginkgo class, three or seven categories of Chinese medicine, its dosage is relatively large, the main ingredients are more clear, whether it is tablets, capsules and pills are relatively consistent in general name, such a category may be the first batch of Chinese medicine belt procurement varieties.
the pilot situation in Qinghai, Jinhua and Henan, there will be a big difference between the collection of Chinese medicine and the chemical medicine.
According to the report of the Health Information Bureau, from the situation of Qinghai collection, Hi Yanping injection, renal injection, sputum hot-clear injection, raw blood treasure particles, compound sea snake capsules, etc., are exclusive varieties, not limited to "generic" products;
Qinghai's pilot is understood to be the State Health Insurance Administration has clearly "guided" it, Qinghai model for the next local pilot, and even the Chinese traditional medicine national harvest has guiding significance, and Jinhua model is also worthy of reference, industry insiders said, Jinhua model has been the formulation of rules and final implementation, made a relatively complete process.
December 31, "Chinese medicine registration classification and declaration information requirements" will be implemented, the State Drug Administration of Chinese medicine for a more detailed classification, on the basis of the standard drugs, biological drugs, identified the same name, exclusive varieties and other classifications, to a certain extent for the collection of paving.
And at a meeting on November 21st, an authority said that the fourth batch of harvesting programmes was screening varieties;
chinese medicine collection, it does not seem far away.
()